Home > Insider Trading > Filing (0001437749-23-015731)

Filing Details

Accession Number:: 0001437749-23-015731
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-24 16:37:55
Reporting Period:: 2023-05-22

Accepted Time:: 2023-05-24 16:37:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356115	Nexpoint Diversified Real Estate Trust	NXDT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1228922	D James Dondero	300 Crescent Court, Suite 700 Dallas TX 75201	See Remarks	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-22	3,545	$10.13	273,050	No	4	P	Indirect	See Footnote
5.50% Series A Cumulative Preferred Shares	Acquisiton	2023-05-23	441	$15.25	15,852	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,825,479	Indirect	See Footnote
Common Stock	89,079	Direct
Common Stock	3,963,399	Indirect	See Footnote
Common Stock	514,012	Indirect	See Footnote
Common Stock	62,809	Indirect	By employee benefit plan
5.50% Series A Cumulative Preferred Shares	45,986	Indirect	See Footnote
5.50% Series A Cumulative Preferred Shares	13,831	Indirect	See Footnote

Footnotes

31,556 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 65,714.39 shares are held by PCMG Trading Partners XXIII, L.P. and 175,780 shares are held by Governance Re Ltd. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
1,275,616 shares are held by Highland Income Fund and 549,863 shares are held by Highland Global Allocation Fund. These entities are managed by NexPoint Asset Management, L.P. ("NexPoint Asset Management"), which is ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
These shares are held by The Dugaboy Investment Trust of which Mr. Dondero is the beneficiary pursuant to an employee purchase plan. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
These shares are held by subsidiaries of The Dugaboy Investment Trust. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
These shares are held by Drugcrafters. Mr. Dondero is the sole managing member of the general partner of Drugcrafters and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
These shares are held by Highland Global Allocation Fund, which is managed by NexPoint Asset Management. Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of shares held by NexPoint Asset Management. The reporting person previously filed a Form 4 on May 22, 2023, which, due to a clerical error, overstated the number of shares held by Highland Global Allocation Fund by 2,407 shares and this report corrects such error. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.